CNS Therapies Contribute Rising Share Of Breakthrough Designations
Executive Summary
Breakthrough program could speed first treatments for tardive dyskinesia, primary progressive multiple sclerosis, and Parkinson's psychosis to market, along with new fast-acting approaches to treatment-resistant depression.